V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160017140 | 160020371 | 1.76 | 17.7 | Palliative (P) | 2021-01-06 | 2021-01-11 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 02 | N | MELPHALAN | 100022048 |
| 160017143 | 160020372 | null | 21.8 | Curative (C) | 2022-03-17 | 2022-03-28 | STS Rhabdomyosarcoma RMS 2005 IVA | null | null | IFOSFAMIDE | 101237274 |
| 160017159 | 160020373 | 1.59 | 104 | Curative (C) | 2021-07-14 | 2021-08-11 | null | 02 | N | STS RHABDO RMS 2005 VIN CYCLO | 101794810 |
| 160017164 | 160020374 | 1.63 | 78.1 | Curative (C) | 2020-10-22 | 2020-10-26 | Ifosfamide | 02 | N | CYCLOPHOSPHAMIDE + VINORELBINE | 100139910 |
| 160017176 | 160020375 | null | 18 | Neo-adjuvant (N) | 2020-11-26 | 2020-11-26 | POMALIDOMIDE | N | N | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 100445707 |
| 160017277 | 160020377 | 1.8 | 88.7 | Neo-adjuvant (N) | 2021-09-07 | 2022-04-29 | Doxorubicin + Ifosfamide | 01 | N | IVADO | 100030899 |
| 160017328 | 160020378 | 0 | null | Palliative (P) | 2020-07-28 | 2021-09-17 | Etoposide oral | 02 | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 101659424 |
| 160017388 | 160020380 | 1.68 | 9.2 | null | 2022-02-10 | 2022-02-18 | Doxorubicin + Ifosfamide | 01 | null | CISPLATIN + VINORELBINE | 101109548 |
| 160017396 | 160020381 | 1.72 | 81.14 | null | 2021-03-09 | 2021-04-05 | POMALIDOMIDE | 01 | null | ETOP 13-18 BEAT-MESO TRIAL | 101280426 |
| 160017419 | 160020382 | 1.71 | 59 | Palliative (P) | 2016-08-31 | 2016-09-14 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 02 | N | CARBOPLATIN + LIPOSOMAL DOX | 100343892 |
| 160017490 | 160020383 | 0 | 92.9 | 03 | 2019-05-24 | 2019-05-26 | NB HRNBL-1 Isotretinoin | 02 | N | DACARBAZINE | 100770715 |
| 160017548 | 160020384 | null | null | null | 2016-10-10 | 2016-11-22 | GEMCITABINE | 02 | null | GEMCITABINE | 100915208 |
| 160017556 | 160020385 | 1.65 | 46.2 | Curative (C) | 2022-03-14 | 2022-04-13 | EW EuroEwing 2012 Arm B VC | 02 | N | NIRAPARIB | 101502820 |
| 160017581 | 160020386 | 1.55 | 36.8 | Palliative (P) | 2022-05-04 | 2022-05-21 | Olaratumab | 02 | N | DACTINOMYCIN + DOXORUBICIN + IFOSFAMIDE + VINCRISTINE | 101161754 |
| 160002009 | 160020387 | null | 76.6 | null | 2020-07-20 | 2020-08-15 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CYCLOPHOSPHAMIDE + TOPOTECAN | 100169851 |
| 160005199 | 160020388 | 1.77 | 72.4 | null | 2020-01-07 | 2020-01-08 | GEMCITABINE | 01 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100797738 |
| 160009395 | 160020389 | 0 | 119 | null | 2021-03-24 | 2021-03-25 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | ETOPOSIDE | 100169012 |
| 160009800 | 160020390 | 1.74 | 72.4 | null | 2020-01-12 | 2020-01-15 | null | 02 | null | RITUXIMAB | 100706611 |
| 160010801 | 160020391 | 1.67 | 94 | Palliative (P) | 2017-06-16 | 2017-10-05 | VAI (Ifos 3g/m2) | 02 | N | NB BEACON TEMOZOLOMIDE ALONE | 100508709 |
| 160011377 | 160020392 | 0 | 47.4 | Palliative (P) | 2021-08-13 | 2021-08-14 | PEMBROLIZUMAB | 02 | null | DACARBAZINE | 100726833 |
| 160013174 | 160020420 | null | null | null | null | 2017-08-01 | null | N | null | CARBOPLATIN + PEMETREXED | 100806418 |
| 160013453 | 160020421 | 1.67 | 68 | Palliative (P) | null | 2022-04-13 | Carboplatin + Pemetrexed | 02 | N | CARBOPLATIN + PEMETREXED | 100513473 |
| 160013860 | 160020425 | 1.82 | null | null | null | 2018-04-10 | null | 02 | null | CARBOPLATIN + PEMETREXED | 101519657 |
| 160014350 | 160020427 | 1.65 | 76.5 | Palliative (P) | 2021-02-24 | 2021-03-11 | Carboplatin + Pemetrexed | 02 | N | CARBOPLATIN + PEMETREXED | 100135632 |
| 160014387 | 160020428 | 1.83 | 82.4 | Palliative (P) | 2020-03-04 | 2020-03-06 | VINORELBINE | 02 | N | VINORELBINE | 101118890 |
| 160014405 | 160020430 | null | 74.75 | Palliative (P) | 2018-03-26 | 2018-04-22 | Trabectedin | null | N | TRABECTEDIN | 101068634 |
| 160014474 | 160020431 | 1.94 | 44 | Palliative (P) | 2021-05-31 | 2021-06-25 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100567955 |
| 160014517 | 160020432 | 1.59 | 78.7 | Palliative (P) | 2019-07-15 | 2019-07-17 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100697104 |
| 160014545 | 160020433 | 1.75 | 66.3 | null | null | null | Vinorelbine (oral) | 02 | null | VINORELBINE | 100089872 |
| 160014994 | 160020435 | 1.54 | 72.35 | null | 2017-06-02 | 2017-06-07 | DOXORUBICIN | 02 | null | TRIAL UNSPECIFIED | 100444770 |
| 160015074 | 160020436 | null | 72.3 | null | 2019-12-09 | 2019-12-09 | DOXORUBICIN | 02 | null | DOXORUBICIN | 100160974 |
| 160015091 | 160020437 | 0 | 100.9 | null | 2020-02-17 | 2020-02-20 | VINORELBINE | 02 | null | VINORELBINE | 100361432 |
| 160015290 | 160020439 | 1.63 | 73 | null | 2017-08-28 | 2017-09-02 | DOXORUBICIN | N | null | VINORELBINE | 101658935 |
| 160015343 | 160020440 | 1.57 | 86.55 | Palliative (P) | 2020-10-07 | 2021-12-24 | DOXORUBICIN | N | N | DOXORUBICIN | 100568238 |
| 160015378 | 160020441 | 1.64 | 62.2 | Adjuvant (A) | 2019-01-17 | 2019-01-25 | VINORELBINE | 02 | N | VINORELBINE | 100356244 |
| 160015442 | 160020442 | 1.54 | 70.4 | Adjuvant (A) | 2020-09-01 | 2020-09-01 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100059880 |
| 160015449 | 160020443 | 1.67 | 70 | Palliative (P) | null | null | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 101614057 |
| 160015528 | 160020444 | 1.68 | 86.5 | null | 2017-04-03 | 2017-04-10 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101653921 |
| 160015535 | 160020445 | 1.6 | 98.8 | Palliative (P) | 2019-11-01 | 2020-05-24 | Doxorubicin 75mg/m2 | 02 | N | NIVOLUMAB | 101424685 |
| 160015679 | 160020446 | 1.61 | 56.85 | Palliative (P) | 2020-01-18 | 2020-02-13 | VINORELBINE | 02 | N | VINORELBINE | 100494943 |
| 160015750 | 160020447 | 1.73 | 78.1 | Palliative (P) | 2018-07-01 | 2018-11-20 | Vinorelbine (oral) | 02 | N | VINORELBINE | 101263802 |
| 160015775 | 160020448 | 1.81 | 81 | Palliative (P) | 2021-04-05 | 2021-09-29 | Bevacizumab 15mg/kg | 02 | N | DOXORUBICIN + OLARATUMAB | 101406357 |
| 160015807 | 160020449 | 1.58 | 65.5 | Adjuvant (A) | 2021-07-11 | 2021-07-23 | Docetaxel + Gemcitabine (prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 100864853 |
| 160015916 | 160020451 | 1.68 | 55 | Neo-adjuvant (N) | 2017-10-10 | 2017-11-03 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 101853045 |
| 160015952 | 160020452 | 1.72 | 79.6 | null | 2020-10-01 | 2020-10-12 | Bevacizumab | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100137761 |
| 160015969 | 160020453 | 1.7 | null | Palliative (P) | 2018-11-21 | 2018-12-06 | Bevacizumab 7.5mg/kg | 02 | N | LIPOSOMAL DOXORUBICIN | 101127652 |
| 160016071 | 160020454 | 1.5 | 98.5 | Palliative (P) | 2020-01-13 | 2020-01-15 | Bevacizumab | 02 | N | DOCETAXEL + GEMCITABINE | 101610285 |
| 160016215 | 160020455 | 1.77 | 69.3 | Neo-adjuvant (N) | 2018-10-03 | 2018-10-08 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN | 101711099 |
| 160016304 | 160020456 | 1.83 | 70.9 | null | 2019-09-18 | 2019-10-03 | Bevacizumab 7.5mg/kg | null | null | CARBOPLATIN + GEMCITABINE | 100017071 |
| 160016323 | 160020457 | 1.7 | 101 | null | 2021-09-26 | 2021-10-05 | Doxorubicin + Olaratumab | 02 | null | DOXORUBICIN + OLARATUMAB | 101402071 |